Title: Legislators Want to Allow Out-of-State Marijuana Investors in Colorado
Date: 18 January 2018
A few years ago, a bill like HB 1011 would have seemed tantamount to Colorado flirting with greedy corporations hell-bent on squeezing out mom-and-pop cannabis shops while raking in mega-profits from the booming industry. But times have changed, says Representative Dan Pabon. He’s the primary House sponsor of HB 1011, which would ease restrictions on the cannabis industry’s growth potential by making the state more attractive to deep-pocketed domestic and international investors.
Last week, three legislators put forward the bill, which would remove barriers to operating publicly traded cannabis companies in the state. (There are a handful of publicly traded cannabis companies in the country, including Denver-based Medicine Man Technologies and Kush Bottles, which are all traded as over-the-counter securities or penny stocks on the OTCQB, not the NASDAQ or major exchanges.) The most significant change proposed under HB 1011 would be opening the doors to an unlimited number of out-of-state investors for cannabis businesses. Investors can include corporations, as ownership is no longer limited to people.
Title: Utah Congressman Introduces Medical Marijuana Research Bill
Author: Weed News
Date: 19 January 2018
Rep. Rob Bishop (R-UT), along with the entire Utah House delegation, has introduced the Marijuana Effective Drug Study Act, H.R. 4825. The bipartisan MEDS Act has also been introduced in the Senate and is aimed at creating a reasoned and responsible environment where the best minds may be able to analyze and examine something about which we know very little. Rep. Bishop is joined by Representatives Blumenauer D-OR, Curtis R-UT, Love R-UT, Norton D-DC, Polis D-CO, Raskin D-MD, and Stewart R-UT as original cosponsors of the MEDS Act.
Rep. Bishop and Utah House Delegation members issued the following statements upon introduction of the bill:
Rep. Rob Bishop: “The MEDS Act is common sense. When presented with an opportunity to alleviate the suffering of those afflicted with painful disorders, we must take it. We don’t know all the answers when it comes to the effects of medical-grade marijuana. This legislation allows scientists and researchers to get at those answers in a responsible manner that isn’t hindered by unnecessary roadblocks.”
Rep. Chris Stewart: “It is well beyond time that we streamline and clarify medical-marijuana research. If there is potential for more Americans to live pain-free lives, we owe it to them to get the facts.”
Title: West Virginia Supreme court now seeking comment on Medical Cannabis Act
Author: Journal News
Date: 22 January 2018
MARTINSBURG–The West Virginia Supreme Court of Appeals is seeking comments from the public on a proposed rule change involving the state’s Medical Cannabis Act, according to a press release from the state’s highest court.
The court is considering an amendment to Rule 1.2 of the Rules of Professional Conduct for attorneys. According to the order entered at a regular term of the Supreme Court of Appeals, Rule 1.2 involves the “scope of representation and allocation of authority between client and lawyer.”
Charles M. Johnson with the Frost, Brown Todd law firm, which has offices in West Virginia, Indiana, Kentucky, Ohio, Pennsylvania, Tennessee, Texas and Virginia, submitted a proposal to the court to consider and adopt a rule change to Rule 1.2 to address the “dilemma faced by West Virginia attorneys who are requested to counsel clients seeking to obtain licenses or to otherwise participate in the programs authorized by the West Virginia Cannabis Act.”
In his proposal, Johnson said in 2016, the Ohio Supreme Court amended the Ohio Rules of Professional Conduct to allow lawyers to provide legal services on behalf of clients engaged in Ohio’s medical marijuana programs.
“I believe the Ohio change to its Rule 1.2(d) is clear and concise,” Johnson said in the proposal. “Accordingly, I propose a similar change to the Rules of Professional Conduct in West Virginia.”
Johnson said many other states that have adopted medical marijuana laws also made changes to their rules of professional conduct to “authorize lawyers in these states to represent these types of clients, recognizing the important role that attorneys play in counseling clients to comply with these laws.”
The proposed addition to the rule, according to the order, is “a lawyer may counsel or assist a client regarding conduct expressly permitted under Senate Bill 386, the West Virginia Medical Cannabis Act, authorizing the use of marijuana for medical purposes and any state rules, regulations, orders, policies and procedures implementing the aforesaid act, as amended. In these circumstances, the lawyer shall advise the client regarding related federal law.”
The Medical Cannabis Act went into effect on July 5, 2017 under the guidance of the West Virginia Office of Medical Cannabis and organized under the West Virginia Bureau of Public Health.